Expression of chemokines and matrix metalloproteinases in early rheumatoid arthritis

Rheumatology

Volumn 40, Issue 9, 2001, Pages 988-994

  Katrib, A ^a   Tak, P P ^b   Bertouch, J V ^a   Cuello, C ^a   McNeil, H P ^a   Smeets, T J M ^b   Kraan, M C ^b   Youssef, P P ^a,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c Rachel Forster Hospital   (Australia)

Author keywords

Chemokines; Matrix metalloproteinases; Rheumatoid arthritis; Tissue inhibitors of matrix metalloproteinases

Indexed keywords

CD68 ANTIGEN; CHEMOKINE; INTERSTITIAL COLLAGENASE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MATRIX METALLOPROTEINASE; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

AGED; ARTICLE; BIOPSY; CELL INFILTRATION; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LEUKOCYTE COUNT; MACROPHAGE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVIUM; VIDEORECORDING;

EID: 0034799718     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/40.9.988     Document Type: Article

References (42)

1. Rheumatoid arthritis. Pathophysiology and implications for therapy
2. Radiographic changes in early rheumatoid disease
3. Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients
4. Therapeutic approaches for early rheumatoid arthritis. How early? How aggressive?
5. Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity
6. Synovial tissue macrophage populations and articular damage in rheumatoid arthritis
7. Synovial tissue macrophages and joint erosion in rheumatoid arthritis
8. The synovial lining cells in chronic arthritis
9. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis
10. Macrophage inflammatory protein-1 alpha. A novel chemotactic cytokine for macrophages in rheumatoid arthritis
11. Expression of monocyte chemotactic and activating factor in rheumatoid arthritis. Regulation of its production in synovial cells by interleukin-1 and tumor necrosis factor
12. Comparative immunolocalization studies of collagenase 1 and collagenase 3 production in the rheumatoid lesion, and by human chondrocytes and synoviocytes in vitro
13. Expression of metalloproteinases and metalloproteinase inhibitor in human arthritic synovium
14. Localization of collagenase mRNA in rheumatoid arthritis synovium by in situ hybridization histochemistry
15. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid other surrogate markers
16. In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium
17. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis
18. Mechanisms of tissue destruction and cellular activation in rheumatoid arthritis
19. Using inhibitors of metalloproteinases to treat arthritis. Easier said than done?
20. Levels of circulating collagenase, stromelysin-1 and tissue inhibitor of matrix metalloproteinases 1 in patients with rheumatoid arthritis. Relationship to serum levels of antigenic keratan sulfate and systemic inflammation
21. Determination of stromelysin-1, 72 and 92 kDa type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-2 in synovial fluid and serum from patients with rheumatoid arthritis
22. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
23. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis
24. Assessing the activity of rheumatoid arthritis
25. Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts
26. Effects of pulse methylprednisolone on cell adhesion molecules in the synovial membrane in rheumatoid arthritis. Reduced E-selectin and intercellular adhesion molecule 1 expression
27. Effects of pulse methylprednisolone on inflammatory mediators in peripheral blood, synovial fluid and synovial membrane in rheumatoid arthritis
28. Expression of adhesion molecules in early rheumatoid synovial tissue
29. Analysis of the cellular infiltrates and expression of cytokines in synovial tissue from patients with rheumatoid arthritis and reactive arthritis
30. Histological appearance of the synovium in early rheumatoid arthritis
31. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
32. Cellular polarization induced by chemokines: A mechanism for leukocyte recruitment?
33. Microscopic measurement of cellular infiltration in the rheumatoid arthritis synovial membrane: A comparison of semi-quantitative and quantitative analysis
34. Quantification of the cell infiltrate in synovial tissue by digital image analysis
35. An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-1pr mouse model
36. The role of chemokines in inflammatory joint disease
37. Predominance of mononuclear cells expressing the chemokine receptor CCR5 in synovial effusions of patients with different forms of arthritis
38. Association of rheumatoid arthritis with a functional chemokine receptor, CCR5
39. Quantitative microscopic analysis of inflammation in rheumatoid arthritis synovial membrane samples selected at arthroscopy compared with samples obtained blindly by needle biopsy
40. Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis
41. Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha
42. Localization of interleukin-1 alpha, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis